Quantum Cyber N.V.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Quantum Cyber N.V.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No other changes.
No other changes.
No thesis.
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Largest filed tie
0
filed ties
—
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Quantum Cyber N.V.
0.73
—
−18.48%
shares held · 10 largest managers
| Manager | Value | % base | |
|---|---|---|---|
| Jane Street | $132,782 | 36.81% | +425.53% |
| Virtu Financial | $64,000 | 17.74% | +42.40% |
| UBS | $40,993 | 11.36% | −69.84% |
| Steward Partners Investment Advisory | $31,400 | 8.70% | −33.33% |
| XTX Topco | $17,884 | 4.96% | −82.28% |
| Manager | Value | % base | |
|---|---|---|---|
| Jane Street | $132,782 | 36.81% | +425.53% |
| Virtu Financial | $64,000 | 17.74% | +42.40% |
| UBS | $40,993 | 11.36% | −69.84% |
| Steward Partners Investment Advisory | $31,400 | 8.70% | −33.33% |
| XTX Topco | $17,884 | 4.96% | −82.28% |
Bull1
Bear2
Expected move
No implied move.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Quantum Cyber N.V..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Quantum Cyber N.V..